{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:22:00Z","timestamp":1793146920181,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR001882"],"award-info":[{"award-number":["KL2TR001882"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["938451"],"award-info":[{"award-number":["938451"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI141202"],"award-info":[{"award-number":["1R01AI141202"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01485-x","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:42:34Z","timestamp":1778924554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u03b2-Glucan chitosan particle provides cross-protection against multi-drug-resistant Candida auris"],"prefix":"10.1038","volume":"11","author":[{"given":"Shakti","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Barbarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman G.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaustav","family":"Das Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunna","family":"Nabeela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teclegiorgis","family":"Gebremariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sondus","family":"Alkhazraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Uppuluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry","family":"Ostroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"1485_CR1","unstructured":"Tracking Candida auris. Centers for Disease Control and Prevention, Vol. 2018. https:\/\/www.cdc.gov\/fungal\/candida-auris\/tracking-c-auris.html (2019)."},{"key":"1485_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/myc.12904","volume":"62","author":"SA Lone","year":"2019","unstructured":"Lone, S. A. & Ahmad, A. Candida auris\u2014the growing menace to global health. Mycoses 62, 620\u2013637 (2019).","journal-title":"Mycoses"},{"key":"1485_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/QCO.0000000000000411","volume":"30","author":"AL Colombo","year":"2017","unstructured":"Colombo, A. L., J\u00fanior, J. N. D. A. & Guinea, J. Emerging multidrug-resistant Candida species. Curr. Opin. Infect. Dis. 30, 528\u2013538 (2017).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"1485_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","volume":"64","author":"SR Lockhart","year":"2017","unstructured":"Lockhart, S. R. et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin. Infect. Dis. 64, 134\u2013140 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1485_CR5","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz, J. F. et al. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nat. Commun. 9, 5346 (2018).","DOI":"10.1038\/s41467-018-07779-6"},{"key":"1485_CR6","doi-asserted-by":"crossref","unstructured":"Chow, N. A. et al. Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. mBio 11, e03364-19 (2020).","DOI":"10.1128\/mBio.03364-19"},{"key":"1485_CR7","doi-asserted-by":"crossref","unstructured":"Khan, T. et al. Emergence of the novel sixth Candida auris Clade VI in Bangladesh. Microbiol. Spectr. 12, e0354023 (2024).","DOI":"10.1128\/spectrum.03540-23"},{"key":"1485_CR8","doi-asserted-by":"crossref","unstructured":"Suphavilai, C. et al. Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study. Lancet Microbe 5, 100878 (2024).","DOI":"10.1016\/S2666-5247(24)00101-0"},{"key":"1485_CR9","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41591-021-01383-w","volume":"27","author":"DM Proctor","year":"2021","unstructured":"Proctor, D. M. et al. Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility. Nat. Med. 27, 1401\u20131409 (2021).","journal-title":"Nat. Med."},{"key":"1485_CR10","unstructured":"Screening for Candida auris Colonization. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/fungal\/candida-auris\/c-auris-screening.html (2019)."},{"key":"1485_CR11","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/jac\/dkx034","volume":"72","author":"SM Rudramurthy","year":"2017","unstructured":"Rudramurthy, S. M. et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J. Antimicrob. Chemother. 72, 1794\u20131801 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"1485_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.micpath.2018.09.014","volume":"125","author":"J de C\u00e1ssia Orlandi Sardi","year":"2018","unstructured":"de C\u00e1ssia Orlandi Sardi, J., Silva, D. R., Soares Mendes-Giannini, M. J. & Rosalen, P. L. Candida auris: epidemiology, risk factors, virulence, resistance, and therapeutic options. Microb. Pathog. 125, 116\u2013121 (2018).","journal-title":"Microb. Pathog."},{"key":"1485_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/mmy\/myz112","volume":"58","author":"MA Sayeed","year":"2020","unstructured":"Sayeed, M. A., Farooqi, J., Jabeen, K. & Mahmood, S. F. Comparison of risk factors and outcomes of Candida auris candidemia with non-Candida auris candidemia: a retrospective study from Pakistan. Med. Mycol. 58, 721\u2013729 (2020).","journal-title":"Med. Mycol."},{"key":"1485_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jcrc.2020.01.004","volume":"57","author":"PS Shastri","year":"2020","unstructured":"Shastri, P. S. et al. Candida auris candidaemia in an intensive care unit \u2013 Prospective observational study to evaluate epidemiology, risk factors, and outcome. J. Crit. Care 57, 42\u201348 (2020).","journal-title":"J. Crit. Care"},{"key":"1485_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293011","volume":"19","author":"C Chadwick","year":"2024","unstructured":"Chadwick, C., De Jesus, M., Ginty, F. & Martinez, J. S. Pathobiology of Candida auris infection analyzed by multiplexed imaging and single cell analysis. PLoS ONE 19, e0293011 (2024).","journal-title":"PLoS ONE"},{"key":"1485_CR16","doi-asserted-by":"crossref","unstructured":"Singh, S. et al. Protective efficacy of Anti-Hyr1p monoclonal antibody against systemic candidiasis due to multi-drug-resistant Candida auris. J. Fungi 9, 103 (2023).","DOI":"10.3390\/jof9010103"},{"key":"1485_CR17","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","volume":"7","author":"M Hoenigl","year":"2022","unstructured":"Hoenigl, M. et al. COVID-19-associated fungal infections. Nat. Microbiol. 7, 1127\u20131140 (2022).","journal-title":"Nat. Microbiol."},{"key":"1485_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/mmy\/myy054","volume":"57","author":"K Forsberg","year":"2019","unstructured":"Forsberg, K. et al. Candida auris: the recent emergence of a multidrug-resistant fungal pathogen. Med. Mycol. 57, 1\u201312 (2019).","journal-title":"Med. Mycol."},{"key":"1485_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/cid\/ciw696","volume":"64","author":"CJ Clancy","year":"2017","unstructured":"Clancy, C. J. & Nguyen, M. H. Emergence of Candida auris: an international call to arms. Clin. Infect. Dis. 64, 141\u2013143 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1485_CR20","unstructured":"CDC. 2019 Antibiotic Resistance Threats Report. https:\/\/www.cdc.gov\/drugresistance\/\/biggest-threats.html (Center for Disease Control, 2021)."},{"key":"1485_CR21","unstructured":"WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. https:\/\/www.who.int\/publications\/i\/item\/9789240060241 (2022)."},{"key":"1485_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1128\/EC.00279-10","volume":"10","author":"Y Liu","year":"2011","unstructured":"Liu, Y. & Filler, S. G. Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot. Cell 10, 168\u2013173 (2011).","journal-title":"Eukaryot. Cell"},{"key":"1485_CR23","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1128\/IAI.00013-13","volume":"81","author":"Y Fu","year":"2013","unstructured":"Fu, Y. et al. Investigation of the function of Candida albicans Als3 by heterologous expression in Candida glabrata. Infect. Immun. 81, 2528\u20132535 (2013).","journal-title":"Infect. Immun."},{"key":"1485_CR24","doi-asserted-by":"publisher","first-page":"0543","DOI":"10.1371\/journal.pbio.0050064","volume":"5","author":"QT Phan","year":"2007","unstructured":"Phan, Q. T. et al. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol. 5, 0543\u20130557 (2007).","journal-title":"PLoS Biol."},{"key":"1485_CR25","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1086\/652407","volume":"201","author":"G Luo","year":"2010","unstructured":"Luo, G. et al. Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target. J. Infect. Dis. 201, 1718\u20131728 (2010).","journal-title":"J. Infect. Dis."},{"key":"1485_CR26","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1128\/IAI.74.5.3039-3041.2006","volume":"74","author":"AS Ibrahim","year":"2006","unstructured":"Ibrahim, A. S., Spellberg, B. J., Avanesian, V., Fu, Y. & Edwards, J. E. The anti-candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis. Infect. Immun. 74, 3039\u20133041 (2006).","journal-title":"Infect. Immun."},{"key":"1485_CR27","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1128\/IAI.73.9.6191-6193.2005","volume":"73","author":"BJ Spellberg","year":"2005","unstructured":"Spellberg, B. J. et al. The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice. Infect. Immun. 73, 6191\u20136193 (2005).","journal-title":"Infect. Immun."},{"key":"1485_CR28","doi-asserted-by":"crossref","unstructured":"Luo, G., Ibrahim, A. S., French, S. W., Edwards, J. E. & Fu, Y. Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis. PLoS ONE 6, e25909 (2011).","DOI":"10.1371\/journal.pone.0025909"},{"key":"1485_CR29","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3389\/fimmu.2018.01349","volume":"9","author":"P Uppuluri","year":"2018","unstructured":"Uppuluri, P. et al. Human anti-Als3p antibodies are surrogate markers of NDV-3A vaccine efficacy against recurrent vulvovaginal candidiasis. Front. Immunol. 9, 1349 (2018).","journal-title":"Front. Immunol."},{"key":"1485_CR30","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/cid\/ciy185","volume":"66","author":"JE Edwards","year":"2018","unstructured":"Edwards, J. E. et al. A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis-a phase 2 randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 66, 1928\u20131936 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"1485_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007460","volume":"15","author":"S Singh","year":"2019","unstructured":"Singh, S. et al. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection. PLoS Pathog. 15, e1007460 (2019).","journal-title":"PLoS Pathog."},{"key":"1485_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-32488-8","volume":"16","author":"S Singh","year":"2025","unstructured":"Singh, S. et al. Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. Sci. Rep. 16, 2582 (2025).","journal-title":"Sci. Rep."},{"key":"1485_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1365-2958.2007.05872.x","volume":"66","author":"JP Latg\u00e9","year":"2007","unstructured":"Latg\u00e9, J. P. The cell wall: a carbohydrate armour for the fungal cell. Mol. Microbiol. 66, 279\u2013290 (2007).","journal-title":"Mol. Microbiol."},{"key":"1485_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41579-022-00796-9","volume":"21","author":"NAR Gow","year":"2022","unstructured":"Gow, N. A. R. & Lenardon, M. D. Architecture of the dynamic fungal cell wall. Nat. Rev. Microbiol. 21, 248\u2013259 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"1485_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-98659-5","volume":"11","author":"T Di Mambro","year":"2021","unstructured":"Di Mambro, T. et al. A new humanized antibody is effective against pathogenic fungi in vitro. Sci. Rep. 11, 1\u201317 (2021). 2021 11:1.","journal-title":"Sci. Rep."},{"key":"1485_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-07738-1","volume":"9","author":"FM Rudkin","year":"2018","unstructured":"Rudkin, F. M. et al. Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis. Nat. Commun. 9, 1\u201316 (2018). 2018 9:1.","journal-title":"Nat. Commun."},{"key":"1485_CR37","first-page":"1","volume":"9","author":"SS Li","year":"2018","unstructured":"Li, S. S. et al. Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida. Nat. Commun. 9, 1\u201313 (2018). 2018 9:1.","journal-title":"Nat. Commun."},{"key":"1485_CR38","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1128\/CVI.00463-13","volume":"20","author":"H Huang","year":"2013","unstructured":"Huang, H., Ostroff, G. R., Lee, C. K., Specht, C. A. & Levitz, S. M. Characterization and optimization of the glucan particle-based vaccine platform. Clin. Vaccin. Immunol. 20, 1585\u20131591 (2013).","journal-title":"Clin. Vaccin. Immunol."},{"key":"1485_CR39","doi-asserted-by":"crossref","unstructured":"Hung, C. Y. et al. Glucan-chitin particles enhance Th17 response and improve protective efficacy of a multivalent antigen (rCpa1) against pulmonary Coccidioides posadasii infection. Infect. Immun. 86, e00070-18 (2018).","DOI":"10.1128\/IAI.00070-18"},{"key":"1485_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/cei.13356","volume":"198","author":"A Abraham","year":"2019","unstructured":"Abraham, A., Ostroff, G., Levitz, S. M. & Oyston, P. C. F. A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens. Clin. Exp. Immunol. 198, 143 (2019).","journal-title":"Clin. Exp. Immunol."},{"key":"1485_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-micro-030117-020406","volume":"71","author":"JP Latg\u00e9","year":"2017","unstructured":"Latg\u00e9, J. P., Beauvais, A. & Chamilos, G. The cell wall of the human fungal pathogen Aspergillus fumigatus: biosynthesis, organization, immune response, and virulence. Annu. Rev. Microbiol. 71, 99\u2013116 (2017).","journal-title":"Annu. Rev. Microbiol."},{"key":"1485_CR42","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1128\/EC.00194-06","volume":"5","author":"CJ Nobile","year":"2006","unstructured":"Nobile, C. J., Nett, J. E., Andes, D. R. & Mitchell, A. P. Function of Candida albicans adhesin hwp1 in biofilm formation. Eukaryot. Cell 5, 1604\u20131610 (2006).","journal-title":"Eukaryot. Cell"},{"key":"1485_CR43","doi-asserted-by":"publisher","unstructured":"Zordan, R. & Cormack, B. Adhesins in opportunistic fungal pathogens. in Candida and Candidiasis, 243-P2, https:\/\/doi.org\/10.1128\/9781555817176.CH16 (2014).","DOI":"10.1128\/9781555817176.CH16"},{"key":"1485_CR44","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1128\/EC.00245-09","volume":"8","author":"IV Ene","year":"2009","unstructured":"Ene, I. V. & Bennett, R. J. Hwp1 and related adhesins contribute to both mating and biofilm formation in Candida albicans. Eukaryot. Cell 8, 1909\u20131913 (2009).","journal-title":"Eukaryot. Cell"},{"key":"1485_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40588-020-00143-7","volume":"7","author":"MV Horton","year":"2020","unstructured":"Horton, M. V. & Nett, J. E. Candida auris infection and biofilm formation: going beyond the surface. Curr. Clin. Microbiol. Rep. 7, 51\u201356 (2020).","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"1485_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/IDR.S116229","volume":"10","author":"S Sarma","year":"2017","unstructured":"Sarma, S. & Upadhyay, S. Current perspective on emergence, diagnosis and drug resistance in Candida auris. Infect. Drug Resist. 10, 155\u2013165 (2017).","journal-title":"Infect. Drug Resist."},{"key":"1485_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhin.2016.08.004","volume":"94","author":"A Chowdhary","year":"2016","unstructured":"Chowdhary, A., Voss, A. & Meis, J. F. Multidrug-resistant Candida auris: \u2018new kid on the block\u2019 in hospital-associated infections? J. Hosp. Infect. 94, 209\u2013212 (2016).","journal-title":"J. Hosp. Infect."},{"key":"1485_CR48","doi-asserted-by":"crossref","unstructured":"Kean, R. & Ramage, G. Combined antifungal resistance and biofilm tolerance: the global threat of Candida auris. mSphere 4, e00458-19 (2019).","DOI":"10.1128\/mSphere.00458-19"},{"key":"1485_CR49","doi-asserted-by":"crossref","unstructured":"Shivarathri, R. et al. Comparative transcriptomics reveal possible mechanisms of Amphotericin B resistance in Candida auris. Antimicrob. Agents Chemother. 66, e0227621 (2022).","DOI":"10.1128\/aac.02276-21"},{"key":"1485_CR50","doi-asserted-by":"crossref","unstructured":"Rapaka, R. R., Dai, G., Zheng, M. & Kolls, J. K. CD4 T Cell regulation of antibodies cross-reactive with fungal cell wall-associated carbohydrates after Pneumocystis murina infection. Infect. Immun. 87, e00158-19 (2019).","DOI":"10.1128\/IAI.00158-19"},{"key":"1485_CR51","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1046\/j.1365-3083.1998.00350.x","volume":"47","author":"G Hetland","year":"1998","unstructured":"Hetland, G., L\u00f8vik, M. & Wiker, H. G. Protective effect of \u03b2-Glucan against Mycobacterium bovis, BCG infection in BALB\/c mice. Scand. J. Immunol. 47, 548\u2013553 (1998).","journal-title":"Scand. J. Immunol."},{"key":"1485_CR52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nri2939","volume":"11","author":"L Romani","year":"2011","unstructured":"Romani, L. Immunity to fungal infections. Nat. Rev. Immunol. 11, 275\u2013288 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"1485_CR53","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1086\/529204","volume":"197","author":"B Spellberg","year":"2008","unstructured":"Spellberg, B. et al. Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity. J. Infect. Dis. 197, 967\u2013971 (2008).","journal-title":"J. Infect. Dis."},{"key":"1485_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000183","volume":"2","author":"LL de Oliveira","year":"2008","unstructured":"de Oliveira, L. L., Coltri, K. C., Barros Cardoso, C. R., Roque-Barreira, M. C. & Panunto-Castelo, A. T Helper 1\u2013Inducing adjuvant protects against experimental Paracoccidioidomycosis. PLoS Negl. Trop. Dis. 2, e183 (2008).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1485_CR55","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-1-60327-210-0_19","volume":"425","author":"A Pitarch","year":"2008","unstructured":"Pitarch, A., Nombela, C. & Gil, C. Cell wall fractionation for yeast and fungal proteomics. Methods Mol. Biol. 425, 217\u2013239 (2008).","journal-title":"Methods Mol. Biol."},{"key":"1485_CR56","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2147\/IDR.S197531","volume":"12","author":"MJ Navarro-Arias","year":"2019","unstructured":"Navarro-Arias, M. J. et al. Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells. Infect. Drug Resist. 12, 783\u2013794 (2019).","journal-title":"Infect. Drug Resist."},{"key":"1485_CR57","doi-asserted-by":"crossref","unstructured":"Dakalbab, S. et al. Uniqueness of Candida auris cell wall in morphogenesis, virulence, resistance, and immune evasion. Microbiol. Res. 286, 127797 (2024).","DOI":"10.1016\/j.micres.2024.127797"},{"key":"1485_CR58","doi-asserted-by":"crossref","unstructured":"Gaffar, N. R., Valand, N. & Venkatraman Girija, U. Candidiasis: insights into virulence factors, complement evasion and antifungal drug resistance. Microorganisms 13, 272 (2025).","DOI":"10.3390\/microorganisms13020272"},{"key":"1485_CR59","doi-asserted-by":"crossref","unstructured":"Vila, T. et al. Comparative evaluations of the pathogenesis of Candida auris phenotypes and Candida albicans using clinically relevant murine models of infections. mSphere 5, e00760-20 (2020).","DOI":"10.1128\/msphere.00760-20"},{"key":"1485_CR60","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1080\/15287390701212224","volume":"70","author":"SH Young","year":"2007","unstructured":"Young, S. H. et al. A comparison of the pulmonary inflammatory potential of different components of yeast cell wall. J. Toxicol. Environ. Health Part A Curr. Issues 70, 1116\u20131124 (2007).","journal-title":"J. Toxicol. Environ. Health Part A Curr. Issues"},{"key":"1485_CR61","doi-asserted-by":"publisher","first-page":"109046","DOI":"10.3389\/fcimb.2014.00145","volume":"4","author":"E Barreto-Bergter","year":"2014","unstructured":"Barreto-Bergter, E. & Figueiredo, R. T. Fungal glycans and the innate immune recognition. Front. Cell. Infect. Microbiol. 4, 109046 (2014).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1485_CR62","doi-asserted-by":"publisher","unstructured":"Van Dyken, S. J. et al. Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and \u03b3\u03b4 T cells. https:\/\/doi.org\/10.1016\/j.immuni.2014.02.003 (2014).","DOI":"10.1016\/j.immuni.2014.02.003"},{"key":"1485_CR63","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.chom.2020.12.002","volume":"29","author":"X Huang","year":"2021","unstructured":"Huang, X. et al. Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies. Cell Host Microbe 29, 210\u2013221.e6 (2021).","journal-title":"Cell Host Microbe"},{"key":"1485_CR64","doi-asserted-by":"publisher","first-page":"e1013114","DOI":"10.1371\/journal.ppat.1013114","volume":"21","author":"D Das","year":"2025","unstructured":"Das, D., Ganesh, S. M., Mishra, A., Netea, M. G. & Thangamani, S. The emerging fungal pathogen Candida auris induces IFN\u03b3 to colonize the skin. PLoS Pathog. 21, e1013114 (2025).","journal-title":"PLoS Pathog."},{"key":"1485_CR65","doi-asserted-by":"crossref","unstructured":"Singh, S. et al. 97. A cross-kingdom vaccine protects against multiple healthcare-associated infections. Open Forum Infect. Dis. 9, ofac492.175 (2022).","DOI":"10.1093\/ofid\/ofac492.175"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01485-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01485-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01485-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:32:17Z","timestamp":1785882737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01485-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1485"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01485-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7942966\/v1","asserted-by":"object"}]},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.S.I. is the founder of Vitalex Biosciences, which is developing novel antifungal immunotherapies. S.S., T.G., S.A., and P.U. own shares in Vitalex Biosciences. All other co-authors do not have competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"156"}}